Skip To Main Content
Bart Jan Kullberg on Muck Rack

Bart Jan Kullberg

As seen in: The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bart Jan

Contact Bart Jan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

|
By George Thompson, Alex Soriano, Oliver A Cornely, Bart Jan Kullberg
| The Lancet Verified
Background Rezafungin is a next-generation, once-a-week echinocandin in development for the treatment of candidaemia and invasive candidiasis and for the prevention of invasive fungal disease caused by Candida, Aspergillus, and Pneumocystis spp after blood and marrow transplantation. We aimed to compare the efficacy and safety of intravenous rezafungin versus intravenous caspofungin in patients with candidaemia and invasive candidiasis.
Open in Who Shared Issue with article?

Lyme borreliosis: diagnosis and management

|
By Bart Jan Kullberg, Hedwig Vrijmoeth, Joppe W Hovius
| bmj.com
Education Lyme borreliosis:...
Open in Who Shared Issue with article?

Cognitive impairments in patients with persistent symptoms attributed to Lyme disease

|
By Bart Jan Kullberg, Sint Maartenskliniek, Anneleen Berende, Fidel J. Vos
| Biomed Central (BMC)
Abstract Background Persistent symptoms attributed to Lyme borreliosis often include self-reported cognitive impairment. However, it remains unclear whether these symptoms can be substantiated by objective cognitive testing. Methods For this observational study, cognitive performance was assessed in 280 adults with persistent symptoms attributed to Lyme borreliosis (as part of baseline data collected for the Dutch PLEASE study).
Open in Who Shared Issue with article?
See all 5 articles